More Argent Biopharma Ltd news
Argent Biopharma LtdASX: RGT

Mxc completes first ArtemiC order, March qtr record revenue

Apr 6, 2021 at 11:55 PM EDT · Issued by Argent Biopharma Ltd

Filed with ASX · Apr 6, 2021 at 11:55 PM EDT · 3 pages · English

On 6ix: 6ix.com/news/mxc-completes-first-artemic-order-march-qtr-record-revenue

Argent Biopharma Ltd on 6ix

In the deck

  • Argent Biopharma — Investor Presentation (April 2021)25 slidesApr 9, 2021

Story so far

  • ArtemiC Phase II Clinical Trial ResultsDec 15, 2020
  • ArtemiC histology on rats confirm no pathological impactOct 14, 2020
  • Update on ArtemiC phase II trial on COVID-19 patientsSep 28, 2020

Earlier from Argent Biopharma

  • Ethics Committee Approval Granted Phase III Clinical TrialMar 22, 2021
  • SwissPharmaCan AG increases initial purchase orderMar 2, 2021
  • MGC Pharma first medicinal cannabis company to list on LSEFeb 3, 2021
  • MGC Pharma Investor PresentationFeb 1, 2021
  • December Quarterly Activity and Cashflow ReportJan 22, 2021

Later from Argent Biopharma

  • Investor presentationApr 9, 2021
  • MGC pharma to acquire medical research company MediCaNLApr 21, 2021
  • March quarterly activity and cashflow reportApr 26, 2021
  • ArtemiC submitted to Health CanadaApr 28, 2021
  • $1M order for ArtemiC Rescue from swiss PharmaCanMay 3, 2021
All Argent Biopharma news releases↗

Follow Argent Biopharma into a list and get an email when it puts out news.

Follow Argent Biopharma
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer